glp-1 ghrelin and GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation GLP-1 | Summary

La metformina y los agonistas del receptor GLP-1 son medicamentos fundamentales en el tratamiento de la diabetes tipo 2, pero pertenecen a clases farmacolgicas completamente diferentes

Source Data Extended Data Figures (download ZIP The source data of all the extended data figures

Based on our study, a GLP-1 receptor agonist-based weight-loss program appears to be superior to non-GLP-1 receptor agonist-based weight-loss programs and intensive lifestyle modification alone for treating post-bariatric surgery weight regain, regardless of surgery type, the researchers wrote

What constitutes unresponsive: Clinically, per manufacture, a patient should not be considered as unresponsive to therapy until less than 5% weight loss over the course of 3 months of GLP1/GIP medication at prescribed dose has been established

Targeted Nutrient Delivery: The injection is administered intramuscularlyusually in the upper arm or hipfor rapid absorption and maximum effectiveness